SCHEMBL7119689

SCHEMBL7119689

CCOC(=O)c1ccc(NC(=O)c2cc([N+](=O)[O-])ccc2Cl)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.64
GAA P10253 4/20 0.64
ALDH1A1 P00352 2/20 0.64
KMT2A Q03164 6/20 0.63
PPARG P37231 6/20 0.63
MEN1 O00255 5/20 0.63
RORC P51449 5/20 0.63
MAPK1 P28482 3/20 0.63
MAPT P10636 3/20 0.63
CYP3A4 P08684 2/20 0.63
LMNA P02545 1/20 0.63
TP53 P04637 1/20 0.63
CYP1A2 P05177 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP2C9 P11712 1/20 0.63
PKM P14618 1/20 0.63
TSHR P16473 1/20 0.63
NFKB1 P19838 1/20 0.63
CYP2C19 P33261 1/20 0.63
THPO P40225 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7131095 0.85 PPARG (0.70) SMN1; SMN2GAAALDH1A1KMT2APPARG
SCHEMBL13532072 0.85 LMNA (0.69) SMN1; SMN2GAAKMT2APPARGMEN1
SCHEMBL7120591 0.84 TAS1R3 (0.70) SMN1; SMN2GAAALDH1A1KMT2APPARG
SCHEMBL7119682 0.84 KMT2A (0.69) SMN1; SMN2GAAALDH1A1KMT2APPARG
SCHEMBL7119937 0.83 KMT2A (0.72) SMN1; SMN2GAAKMT2APPARGMEN1
SCHEMBL7120764 0.83 KMT2A (0.76) SMN1; SMN2GAAKMT2APPARGMEN1
SCHEMBL9644607 0.83 LMNA (0.73) SMN1; SMN2GAAALDH1A1KMT2AMEN1
SCHEMBL7130609 0.83 RORC (0.84) SMN1; SMN2GAAKMT2APPARGMEN1
SCHEMBL7125233 0.82 KMT2A (0.70) SMN1; SMN2GAAALDH1A1KMT2APPARG
SCHEMBL7120849 0.82 KMT2A (0.78) SMN1; SMN2GAAKMT2APPARGMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD SMN1; SMN2 3743/4885GAA 2094/4885ALDH1A1 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.